Drug recall · November 26, 2014
Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL recall
Why: Non-Sterility
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplied in 11 mL Sterile Syringes, Rx only, Compounded med, Single use only, (Red Block) ABRAMS ROYAL Compounding Pharmacy, Dallas, TX
- Lots / codes
Lot# 041013-13 (also been written as "041013@13") Exp: 06/09/2013
- Quantity
- 50 syringes
- Company
- Abrams Royal Pharmacy, Dallas, TX
- Distribution
- Texas
- Initiated
- April 19, 2013 · Voluntary: Firm initiated
- Classified
- November 17, 2014
- Reported
- November 26, 2014
- Ended
- October 7, 2016
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Epinephrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.